|
|
||||||||
Ann Thorac Surg 1985;40:7-10
© 1985 The Society of Thoracic Surgeons
Ohio Heart and Thoracic Surgery Center, Inc., and the Mt. Carmel Medical Center, Columbus, OH
Accepted for publication November 15, 1984.
* Address reprint requests to Dr. Brahos, Ohio Heart and Thoracic Surgery Center, Inc., 931 Chatham Lane, Columbus, OH 43221
This study reviews the experience in a community hospital with aortocoronary bypass in 100 consecutive patients following failed percutaneous transluminal coronary angioplasty (PTCA) in terms of timing of intervention, morbidity, and mortality. Patients undergoing operation within 24 hours of PTCA are defined as the urgent group (68%) and those with intervention at greater than 24 hours, the elective group (32%). Mean interval from PTCA to operation was 43.5 days; among patients with apparently initially successful PTCA and hospital discharge, mean interval to operation was 138 days. Complete revascularization was carried out in all patients using standard techniques. Although the difference was not statistically significant, patients in the urgent group required intraaortic balloon pump support and inotropic infusions more often and experienced greater postoperative blood loss. Significant increases in the use of lidocaine and blood products were noted in the urgent group. The rates of major complications were 54.4% in the urgent group and 18.8% in the elective group. Mortality was 4.4% in the urgent group and 3.1% in the elective group (not significant); all deaths were cardiac related. There were no late deaths among survivors followed for 3 months to 4 years; 86% were in Functional Class I.
We conclude that PTCA is a reasonable approach for some patients with ischemic heart disease. However, mandatory urgent aortocoronary bypass in these patients carries an increased morbidity and mortality, and patients should be selected with care.
This article has been cited by other articles:
![]() |
S. C. Silvestry and P. K. Smith Current status of cardiac surgery in the abciximab-treated patient Ann. Thorac. Surg., August 1, 2000; 70(2): S12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wang, S. R. Gundry, G. Van Arsdell, A. J. Razzouk, A. C. Hill, M. Sjolander, K. A. Cavazos, J. M. Brewer, E. E. Vyhmeister, and L. L. Bailey Percurtaneous transluminal coronary angioplasty failures in patients with multivessel diseaseIs there an increased risk? J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 214 - 223. [Abstract] [Full Text] |
||||
![]() |
F. L. Caes and G. J. Van Nooten Use of internal mammary artery for emergency grafting after failed coronary angioplasty Ann. Thorac. Surg., May 1, 1994; 57(5): 1295 - 1299. [Abstract] [PDF] |
||||
![]() |
R. T. Baldwin, S. Slogoff, G. P. Noon, M. Sekela, O. H. Frazier, S. K. Edelman, and W. K. Vaughn A model to predict survival at time of postcardiotomy intraaortic balloon pump insertion Ann. Thorac. Surg., April 1, 1993; 55(4): 908 - 913. [Abstract] [PDF] |
||||
![]() |
A. M. Borkon, T. L. Failing, J. M. Piehler, D. A. Killen, M. L. Hoskins, and W. A. Reed Risk analysis of operative intervention for failed coronary angioplasty Ann. Thorac. Surg., November 1, 1992; 54(5): 884 - 891. [Abstract] [PDF] |
||||
![]() |
M. A. Greene, L. A. Gray Jr, A. D. Slater, B. L. Ganzel, and C. Mavroudis Emergency aortocoronary bypass after failed angioplasty Ann. Thorac. Surg., February 1, 1991; 51(2): 194 - 199. [Abstract] [PDF] |
||||
![]() |
K. S. Naunheim, A. C. Fiore, D. C. Fagan, L. R. McBride, H. B. Barner, D. G. Pennington, V. L. Willman, M. J. Kern, U. Deligonul, M. C. Vandormael, et al. Emergency coronary artery bypass grafting for failed angioplasty: Risk factors and outcome Ann. Thorac. Surg., June 1, 1989; 47(6): 816 - 823. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |